BALYASNY ASSET MANAGEMENT L.P. 13D and 13G filings for Nasus Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 06:06 am Sale | 2026-06-30 | 13G | NASUS PHARMA LTD NSRX | BALYASNY ASSET MANAGEMENT L.P. | 1,169,909 9.990% | -1 (-0.00%) | Filing |